Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. CRIS
CRIS logo

CRIS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

CRIS News

Curis Reports Significant Q4 2025 Profit Improvement

Mar 20 2026Yahoo Finance

Curis, Inc. Q4 2025 Earnings Call Insights

Mar 19 2026seekingalpha

Curis (CRIS) Q4 2025 Earnings Call Transcript

Mar 19 2026NASDAQ.COM

Curis Reports 2025 Financial Results and Financing Progress

Mar 19 2026PRnewswire

Curis Reports Q4 Earnings with Mixed Results

Mar 19 2026seekingalpha

Curis Scheduled to Announce Q4 Earnings Results

Mar 18 2026seekingalpha

Curis to Report Q4 2025 Financial Results on March 19, 2026

Mar 12 2026Newsfilter

Curis Closes $80.8 Million PIPE Financing to Advance Emavusertib Development

Jan 09 2026PRnewswire

Curis Closes $80.8 Million PIPE Financing to Advance Cancer Drug Development

Jan 09 2026Newsfilter

Innovative Eyewear Inc Reports 45% Year-over-Year Sales Growth in Q4

Jan 07 2026Benzinga

UniFirst Corp Reports Mixed Q1 Results, Shares Drop 4%

Jan 07 2026Benzinga

Curis Secures $80.8 Million PIPE Financing to Support R&D Efforts

Jan 07 2026Newsfilter

Curis Secures $80.8 Million in PIPE Financing

Jan 07 2026PRnewswire

Biotech Stocks Rise in After-Hours Trading Driven by Data Expectations and Momentum Buying

Dec 11 2025NASDAQ.COM

Curis Reports 62.5% of AML Patients Achieve Undetectable MRD in Latest Study

Dec 09 2025Newsfilter

Curis to Showcase at the 30th Annual SNO Conference

Nov 14 2025Newsfilter